TT-01688-CL

N/A

Report date: 2023/05/24 14:39:28
NME

Base Information

Drug NameTT-01688-CL
Drug Alias NameTT-01688-CL片TT-01688-CLTT-01688LC51-0255LC-51-0255
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSphingosine 1-phosphate receptor modulators
TargetsSphingosine 1-phosphate receptor
Therapy Area/IndicationsDermatitis, AtopicColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesLg Chemical Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesTransThera Sciences (Nanjing) Inc
Inactive CompaniesN/A
Active IndicationsDermatitis, AtopicColitis, Ulcerative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A